Skip to main content

Health Canada issues Evusheld alert on risk of prophylaxis or treatment failure due to antiviral resistance

Evusheld was only recently approved in Canada as a treatment for mild to moderate COVID-19.
10/28/2022

Register for free access or login.

Canadian Healthcare Network is an independent online community for Canadian healthcare professionals in medicine and pharmacy. It is the online home of the Medical Post and Pharmacy Practice + Business.

Membership is free and allows doctors, pharmacists, nurses and many others to get the latest breaking news, updates on clinical guidelines and read (and even write) commentary from your healthcare peers.

X
This ad will auto-close in 10 seconds